Pediatric Hereditary Polyposis Syndromes: Diagnosis, Surveillance, and Management Across Evolving Guidelines
Hussein Khalifeh1, Xiaoyi Zhang1, Brett J Hoskins2,3
1Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Indiana University School of Medicine, Riley Hospital for Children at IU Health, Indianapolis, IN, USA.
Insights
Pediatric hereditary polyposis syndrome management requires lifelong surveillance. Synthesizing guidelines can improve care consistency, though implementation gaps persist.
Area of Science:
- Pediatric Gastroenterology
- Clinical Genetics
- Hereditary Cancer Syndromes
Background:
- Lifelong surveillance and multidisciplinary care are crucial for pediatric hereditary polyposis syndromes.
- Pediatric care for these syndromes shows significant variability despite evolving guidelines.
Purpose of the Study:
- To synthesize current society recommendations for pediatric hereditary polyposis syndromes.
- To contextualize guideline implementation within pediatric clinical practice.
Main Methods:
- A narrative review of current literature and major hereditary polyposis guideline frameworks.
- Emphasis on pediatric considerations for familial adenomatous polyposis (FAP), juvenile polyposis syndrome (JPS), Peutz-Jeghers syndrome (PJS), and other rare syndromes.
Main Results:
- Guidelines generally agree on syndrome-directed surveillance but vary in pediatric specificity, initiation age, and intervals.
- Key pediatric distinctions include specific screenings (e.g., hepatoblastoma, HHT) and early small-bowel surveillance for PJS.
- Implementation gaps exist in managing genotype-negative disease, surgical referral timing, endoscopy use, and transition to adult care.
Conclusions:
- An integrated synthesis of recommendations, individualized by patient factors, can enhance pediatric polyposis syndrome management.
- Consolidated guideline tables can serve as practical tools to improve care consistency.
- Further study is needed to establish the impact of these tools on clinical implementation and patient outcomes.
Purpose:
Pediatric hereditary polyposis syndromes require lifelong surveillance and multidisciplinary management, yet pediatric care remains variable despite multiple evolving guideline frameworks. This review synthesizes current society recommendations and contextualizes their implementation within pediatric clinical practice.
Methods:
A narrative review was performed using current literature and major hereditary polyposis guideline frameworks selected for their pediatric relevance and clinical applicability, with emphasis on pediatric considerations in familial adenomatous polyposis (FAP), attenuated FAP, juvenile polyposis syndrome (JPS), Peutz-Jeghers syndrome (PJS), and rare or emerging polyposis syndromes.
Results:
The reviewed guidelines are broadly concordant in supporting syndrome-directed surveillance, but differ in pediatric specificity, age of initiation, surveillance intervals, and emphasis on extracolonic manifestations. The accompanying tables synthesize recommendations across major societies and highlight areas of concordance and variability for FAP, JPS, PJS, and less common syndromes. Key pediatric distinctions include hepatoblastoma screening in APC-associated disease, hereditary hemorrhagic telangiectasia evaluation in SMAD4-associated JPS, and early small-bowel surveillance in PJS to prevent intussusception. Persistent implementation gaps include management of genotype-negative disease, timing of surgical referral, use of advanced therapeutic endoscopy, and transition to adult care.
Conclusion:
Pediatric hereditary polyposis syndrome management may benefit from an integrated synthesis of society recommendations, individualized by phenotype, genotype, polyp burden, available expertise, and local resources. Consolidated guideline-based tables may serve as practical reference tools that facilitate more consistent pediatric care, although their impact on clinical implementation, consistency of care, and patient outcomes remains to be established.
Related Concept Videos
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Chronic Pancreatitis II: Collaborative Care
Assessment:
